Novel biomarkers for the diagnosis of ischaemic stroke;Accidents vasculaires cérébraux: De nouveaux marqueurs biologiques en perspective

Revue Francophone des Laboratoires

Volumn 39, Issue 409, 2009, Pages 75-80

  Beaudeux, Jean Louis ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

Biomarker; Cerebral stroke; Haemorrhage; Inflammation; Ischemia

Indexed keywords

EID: 60749117509     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-035x(09)70203-5     Document Type: Review

References (28)

1. Bejot Y, Evolution des taux d'incidences des accidents vasculaires cérébraux à Dijon, France, entre 1985 et 2004. Bulletin épidémiologique hebdomadaire, 7 mai 2007.
2. Castillo J. Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischemia. Molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;15(suppl.1):1-5.
3. Castellanos M, Blanco M, Pedraza S, Serena J, Leira R, Silva Y, Castillo J, Davalos A. Molecular markers of endothelial injury and diffusion-weighted MRI in acute ischemic stroke. Stroke 2004;35:329.
4. Hopkins SJ. The pathophysiological role of cytokines. Legal Med 2003;5:S45-7.
5. Rodriguez-Yanez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 2008;21:353-7.
6. Whiteley W, Tseng MH, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke. Stroke 2008;39:172-6.
7. Lehmann S, Beaudeux JL. Evaluation biochimique des lésions neurodégénératives et des lésions cérébrales aiguës. In: Biochimie médicale : marqueurs actuels et perspectives. Durand et Beaudeux Coord., Lavoisier Eds (2008).
8. Nash DL, Bellolio MF, Stead LG. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit Care 2008;8:301-7.
9. Kokocinska D, Wieczorek P, Partyka R, Jarzab J, Jałowiecki P, Sikora J. The diagnostic utility of S-100B protein and TPA in patients with ischemic stroke. Neuro Endocrinol Lett 2007;28:693-8.
10. Rouannet F, Brouste Y, Meissner W, Orgogoz JM. Use of triage stroke panel in a neurological emergency service. Cerebrovasc Dis 206;21:123.
11. Laskowitz DT, Blessing R, Floyd J, White WD, Lynch JR. Panel of biomarkers predicts stroke. Ann NY Acad Sci 2005;1053:30.
12. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, Mc Pherson PH, Nakamura KK, et al. Early biomarkers of stroke. Clin Chem 2003;49:1733-9.
13. Lynch JR, Belssing R, White WD, Grocott HP, Newman MF, et al. Novel diagnostic test for acute stroke. Stroke 2004;35:57-63.
14. Castillo J, Davalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060-5.
15. Vila N, Castillo J, Davalos A, Chamorro A, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-9.
16. Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M. Evaluation of serum S100β as a surrogate marker for long-term outcome and infarct volume in acute mille cerebral artery infarction. Arch Neurol 2005;62:1130-4.
17. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-60.
18. Rosell A, Alvarez-Sabin J, Arenilla JF, Rovira A, Delgado P, Fernandez-Cadenas I, et al. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005;36:1415-20.
19. Wunderlich MT, Wallesch CW, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci 2004;227:49-53.
20. Christensen H, Boysen G. C-reactive protein and white cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis 2004;18:214-9.
21. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-8.
22. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic strocke correlate with brain infarct volume, stroke severity, and long-term outcome, BMC Neurology 2004; 4:2.
23. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribo M, Chacon P, et al. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003;23:1403-7.
24. Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 2000;31:3034-40.
25. Hermann M, Vos P, Wunderlich MT, de Brujin CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S100B and glial fibrillary acidic protein. Stroke 2000;31:2670-7.
26. Foerch C, Otto B, Singer OC, Neumann-Haefelin T, Yan B, Berkefeld J, et al, Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 2004;35:2160-4.
27. Fowler SB, Mancini B. Predictive value of biochemical markers in stroke. J Neurosc Nurs 2007;39(1):58-60.
28. Castellanos M, Serena J. Applicability of biomarkers in ischemic stroke, Cerebrovasc Dis 2007;24(suppl 1):7-15.